300 related articles for article (PubMed ID: 19345033)
1. Factors associated with mortality in bacteremic patients with hematologic malignancies.
Tumbarello M; Spanu T; Caira M; Trecarichi EM; Laurenti L; Montuori E; Fianchi L; Leone F; Fadda G; Cauda R; Pagano L
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):320-6. PubMed ID: 19345033
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW
J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients.
Shi SH; Kong HS; Xu J; Zhang WJ; Jia CK; Wang WL; Shen Y; Zhang M; Zheng SS
Transpl Infect Dis; 2009 Oct; 11(5):405-12. PubMed ID: 19638006
[TBL] [Abstract][Full Text] [Related]
4. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
[TBL] [Abstract][Full Text] [Related]
5. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization.
Blot S; Vandewoude K; De Bacquer D; Colardyn F
Clin Infect Dis; 2002 Jun; 34(12):1600-6. PubMed ID: 12032895
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study.
Venditti M; Falcone M; Micozzi A; Carfagna P; Taglietti F; Serra PF; Martino P
Haematologica; 2003 Aug; 88(8):923-30. PubMed ID: 12935981
[TBL] [Abstract][Full Text] [Related]
7. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
Trecarichi EM; Tumbarello M; Spanu T; Caira M; Fianchi L; Chiusolo P; Fadda G; Leone G; Cauda R; Pagano L
J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650
[TBL] [Abstract][Full Text] [Related]
8. Risk of bacteraemia and mortality in patients with haematological malignancies.
Nørgaard M; Larsson H; Pedersen G; Schønheyder HC; Sørensen HT
Clin Microbiol Infect; 2006 Mar; 12(3):217-23. PubMed ID: 16451407
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
Paul M; Gafter-Gvili A; Leibovici L; Bishara J; Levy I; Yaniv I; Shalit I; Samra Z; Pitlik S; Konigsberger H; Weinberger M
Isr Med Assoc J; 2007 Jun; 9(6):424-9. PubMed ID: 17642387
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of bloodstream infections in burn patients: An 11-year retrospective study.
Patel BM; Paratz JD; Mallet A; Lipman J; Rudd M; Muller MJ; Paterson DL; Roberts JA
Burns; 2012 Aug; 38(5):685-90. PubMed ID: 22348799
[TBL] [Abstract][Full Text] [Related]
11. Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay.
Sostarich AM; Zolldann D; Haefner H; Luetticken R; Schulze-Roebecke R; Lemmen SW
Infection; 2008 Feb; 36(1):31-5. PubMed ID: 18231721
[TBL] [Abstract][Full Text] [Related]
12. How long does it take to "rule out" bacteremia in children with central venous catheters?
Shah SS; Downes KJ; Elliott MR; Bell LM; McGowan KL; Metlay JP
Pediatrics; 2008 Jan; 121(1):135-41. PubMed ID: 18166567
[TBL] [Abstract][Full Text] [Related]
13. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies.
Todeschini G; Tecchio C; Borghero C; D'Emilio A; Pegoraro E; de Lalla F; Benedetti P; Spolaore P; Pellizzer G
J Infect; 2006 Oct; 53(4):266-73. PubMed ID: 16388852
[TBL] [Abstract][Full Text] [Related]
14. Evolving pathogens in the surgical intensive care unit: a 6-year experience.
Starnes MJ; Brown CV; Morales IR; Hadjizacharia P; Salim A; Inaba K; Rhee P; Demetriades D
J Crit Care; 2008 Dec; 23(4):507-12. PubMed ID: 19056014
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies.
Chong Y; Yakushiji H; Ito Y; Kamimura T
Int J Infect Dis; 2011 Apr; 15(4):e277-81. PubMed ID: 21324723
[TBL] [Abstract][Full Text] [Related]
16. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies.
Micozzi A; Venditti M; Monaco M; Friedrich A; Taglietti F; Santilli S; Martino P
Clin Infect Dis; 2000 Sep; 31(3):705-11. PubMed ID: 11017819
[TBL] [Abstract][Full Text] [Related]
17. Haematological malignancies--a predictor of a poor outcome in patients with bacteraemia.
Nørgaard M; Larsson H; Pedersen G; Schønheyder HC; Sørensen HT
J Infect; 2006 Sep; 53(3):190-8. PubMed ID: 16352338
[TBL] [Abstract][Full Text] [Related]
18. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
19. Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey.
Trecarichi EM; Pagano L; Candoni A; Pastore D; Cattaneo C; Fanci R; Nosari A; Caira M; Spadea A; Busca A; Vianelli N; Tumbarello M;
Clin Microbiol Infect; 2015 Apr; 21(4):337-43. PubMed ID: 25595706
[TBL] [Abstract][Full Text] [Related]
20. Bacteremia in patients with hematological malignancies. Analysis of risk factors, etiological agents and prognostic indicators.
Pagano L; Tacconelli E; Tumbarello M; Laurenti L; Ortu-La Barbera E; Antinori A; Caponera S; Cauda R; Leone G
Haematologica; 1997; 82(4):415-9. PubMed ID: 9299853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
